University of California, Irvine: Prostatic Neoplasms trials

The registry lists 10 Prostatic Neoplasms studies with University of California, Irvine as lead sponsor. 2 are open to participants now and 3 have results posted.

Phase 2 4No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Utilization of Flotufolastat 18F PET for Post-Focal Therapy Prostate Cancer EvaluationNot yet recruitingNCT07568756Phase 2
• Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialRecruitingNCT06580002Phase 2
• Transurethral Ultrasonic Imaging For Detection and Classification of Prostate CancerTerminatedNCT02307552Not applicableResults posted
• Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer PatientsCompletedNCT01882985Phase 2Results posted
• Trial of Dasatinib (Sprycel®) in Subjects With Hormone-refractory Prostate CancerCompletedNCT00570700Phase 2Results posted
• Early Prostate Cancer: Predicting Treatment ResponseStatus unknownNCT03770351
• Imaging of Prostate Cancer Using Two-dimensional MR Spectroscopy and Diffusion Tensor ImagingWithdrawnNCT00611065Not applicable
• Molecular Urine Tests for Prostate CancerCompletedNCT00581516
• Early Detection and Staging of Endobronchial Lung and Pleural Cancer, Airway Injury, and Prostate CancerWithdrawnNCT00581503
• UCI 03-72 Prostate Cancer Detection by Serum Proteomic ProfilingTerminatedNCT00355758